世界の新生児スクリーニング市場(~2026年):製品別(機器、消耗品)、検査種類別(乾燥血液スポット、聴覚スクリーニング、CCHD)、技術別(タンデム質量分析、イムノアッセイ、酵素アッセイ、分子、パルスオキシメトリ)、エンドユーザー別(病院)

◆英語タイトル:Newborn Screening Market by Product (Instrument, Consumables), Test Type (Dried Blood Spot, Hearing Screening, CCHD),Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Molecular, Pulse Oximetry),End User (Hospitals) - Global Forecast to 2026
◆商品コード:MD2549
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2021年2月26日
◆ページ数:171
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

マーケッツアンドマーケッツ社は、世界の新生児スクリーニング市場規模が2021年9億ドルから2026年13億ドルまで、年平均8.3%成長すると予測しています。本調査レポートでは、新生児スクリーニングの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(消耗品、器具)分析、検査別(乾燥血液スポット、聴覚スクリーニング、先天性心臓欠損)分析、技術別(イムノアッセイ・酵素アッセイ、タンデム質量分析、分子アッセイ、聴覚スクリーニング技術、パルスオキシメトリ)分析、エンドユーザー別(臨床研究所、病院)分析、地域別分析、競争状況、企業情報などを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・新生児スクリーニングの世界市場規模:製品別(消耗品、器具)
・新生児スクリーニングの世界市場規模:検査別(乾燥血液スポット、聴覚スクリーニング、先天性心臓欠損)
・新生児スクリーニングの世界市場規模:技術別(イムノアッセイ・酵素アッセイ、タンデム質量分析、分子アッセイ、聴覚スクリーニング技術、パルスオキシメトリ)
・新生児スクリーニングの世界市場規模:エンドユーザー別(臨床研究所、病院)
・新生児スクリーニングの世界市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The global newborn screening market size is projected to reach USD 1.3 billion by 2026 from USD 0.9 billion in 2021, at a CAGR of 8.3% during the forecast period.”
The rapid growth in the newborn screening rate, the increasing prevalence of newborn metaboloic, hormonal and genetic diseases, and favourable government policies are driving the growth of the newborn screening.

“newborn Disorder screening instruments segment accounted for the largest share of newborn screening market in 2019.”
Based on instrument, the newborn screening market is segmented into newborn disorder screening instruments, newborn hearing screening instruments, and pulse oximeters. Newborn disorder screening instruments accounted for the largest share in 2019. These instruments can screen for the majority of newborn disorders and thus see the highest demand. Government support and the implementation of newborn screening programs also support the market.

“Dry blood spot tests accounted for the largest share of the newborn screening market in 2019.”
The newborn screening market, by test, is segmented into dry blood spot tests, hearing screening tests, and critical congenital heart defect (CCHD) screening tests. In 2019, the dry blood spot tests segment accounted for the largest share of the newborn screening market due to the wide acceptance of dry blood spot tests for screening disorders. Most metabolic, hormonal, and genetic disorders are diagnosed using dry blood spot tests.

“Asia Pacific estimated to register the highest CAGR during the forecast period.”
In this report, the newborn screening market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to grow at the highest growth rate during the forecast period. The growth in this market is primarily driven by the presence of a large pool of newborn, increasing prevalence of newborn disorders, incresing awareness abou early diagnosis of disease, and rising focus of key players in this region.

Breakdown of primary supply-side interviews, by company type, designation, and region:
• By Company Type: Tier 1 (70%) , Tier 2 (20%), and Tier 3 (10%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (35%), Europe (24%), Asia Pacific (25%), and Rest of the World (16%)

List of players profiled in this report:
1. PerkinElmer (US)
2. Demant A/S (Denmark)
3. Natus Medical (US)
4. Bio-Rad Laboratories (US)
5. Danaher Corporation (US)
6. Medtronic (Ireland)
7. Chromsystems Instruments & Chemicals GmbH (Germany)
8. Trivitron Healthcare (India)
9. Baebies (US)
10. Parseq Lab (Russia)
11. Recipe Chemicals+Instruments (Germany)
12. Bio-Rad Laboratories (US)
13. Zivak Technology (Turkey)
14. Demant (Denmark)
15. CAMAG (Switzerland)
16. Otodynamics Ltd (UK)
17. Zentech S.A. (Belgium)
18. Hill-Rom Holdings (US)
19. Intelligent Hearing Systems Corp (US)
20. Waters (US)
21. Thermo Fischer Scientific (US)
22. MP Biomedicals (US)
23. CENTOGENE N.V. (Germany)
24. DRG International (US)
25. Regis Technologies (US).

Research Coverage
This report studies the newborn screening market based on product and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total newborn screening market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the newborn screening offered by the top 10 players in the market. The report analyzes the newborn screening market by product and region
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various newborn screening across key geographic regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the newborn screening market
• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the newborn screening market

【レポートの目次】

1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 25
1.3 INCLUSIONS & EXCLUSIONS 25
1.4 MARKET SCOPE 26
1.4.1 MARKETS COVERED 26
1.4.2 YEARS CONSIDERED FOR THE STUDY 26
1.5 CURRENCY 27
1.6 LIMITATIONS 27
1.7 STAKEHOLDERS 27
1.8 SUMMARY OF CHANGES 27
1.9 LIMITATIONS OF THE CURRENT EDITION 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
FIGURE 1 RESEARCH DESIGN 29
2.1.1 SECONDARY DATA 29
2.1.1.1 Secondary sources 30
2.1.2 PRIMARY DATA 30
2.1.2.1 Key data from primary sources 30
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 31
2.2 MARKET SIZE ESTIMATION 32
2.2.1 BOTTOM-UP APPROACH 32
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 32
FIGURE 4 MARKET SIZE ESTIMATION: PATIENT-BASED METHODOLOGY 32
2.2.2 TOP-DOWN APPROACH 33
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 33
2.2.3 GROWTH FORECAST 33
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 34
FIGURE 6 DATA TRIANGULATION METHODOLOGY 34
2.4 ASSUMPTIONS FOR THE STUDY 35
3 EXECUTIVE SUMMARY 36
FIGURE 7 NEWBORN SCREENING MARKET, BY PRODUCT, 2021 VS. 2026 36
FIGURE 8 NEWBORN SCREENING INSTRUMENTS MARKET, BY TYPE, 2021 VS. 2026 37
FIGURE 9 NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021 VS. 2026 37
FIGURE 10 NEWBORN SCREENING MARKET, BY TEST, 2021 VS. 2026 38
FIGURE 11 NEWBORN SCREENING MARKET, BY END USER, 2021 VS. 2026 38
FIGURE 12 GEOGRAPHIC SNAPSHOT OF THE NEWBORN SCREENING MARKET 39
4 PREMIUM INSIGHTS 40
4.1 NEWBORN SCREENING MARKET OVERVIEW 40
FIGURE 13 FAVORABLE GOVERNMENT POLICIES AND AVAILABILITY OF NEWBORN SCREENING PROGRAMS TO SUPPORT THE NEWBORN SCREENING MARKET 40
4.2 NEWBORN SCREENING MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 40
FIGURE 14 CONSUMABLES ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019 40
4.3 NORTH AMERICAN NEWBORN SCREENING MARKET, BY PRODUCT AND COUNTRY 41
FIGURE 15 US DOMINATES THE NEWBORN SCREENING MARKET 41
4.4 NEWBORN SCREENING MARKET: GEOGRAPHIC SNAPSHOT 41
FIGURE 16 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
FIGURE 17 NEWBORN SCREENING MARKET: DRIVERS,
OPPORTUNITIES, AND CHALLENGES 42
5.2.1 DRIVERS 42
5.2.1.1 Rising prevalence of newborn disorders 42
5.2.1.2 Newborn screening programs and legislation 43
5.2.1.3 Favorable reimbursement policies 43
5.2.2 OPPORTUNITIES 43
5.2.2.1 Growth potential of emerging economies 43
5.2.3 CHALLENGES 44
5.2.3.1 Availability of refurbished products 44
5.3 COVID-19 IMPACT ON NEWBORN SCREENING 44
5.4 PRICING ANALYSIS 44
5.5 PATENT ANALYSIS 45
5.6 TRADE ANALYSIS 46
5.6.1 TRADE ANALYSIS FOR SPECTROMETERS 46
TABLE 1 EXPORT DATA FOR SPECTROMETERS, SPECTROPHOTOMETERS AND SPECTROGRAPHS USING OPTICAL RADIATIONS, SUCH AS UV, VISIBLE,
IR, BY COUNTRY, 2016—2020 (USD MILLION) 46
TABLE 2 IMPORT DATA FOR SPECTROMETERS, SPECTROPHOTOMETERS AND SPECTROGRAPHS USING OPTICAL RADIATIONS, SUCH AS UV, VISIBLE,
IR, BY COUNTRY, 2016—2020 (USD MILLION) 46
5.7 VALUE CHAIN ANALYSIS 47
FIGURE 18 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES 47
5.8 SUPPLY CHAIN ANALYSIS 48
FIGURE 19 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY FOR
PROMINENT COMPANIES 48
5.9 ECOSYSTEM ANALYSIS 49
5.10 TECHNOLOGY ANALYSIS 49
5.11 PESTLE ANALYSIS 50
5.12 REGULATORY LANDSCAPE 51
FIGURE 20 510(K) APPROVAL PROCESS 51
5.13 PORTER’S FIVE ANALYSIS 52
FIGURE 21 NEWBORN SCREENING MARKET, PORTER’S FIVE ANALYSIS 52
6 NEWBORN SCREENING MARKET, BY PRODUCT 53
6.1 INTRODUCTION 54
TABLE 3 NEWBORN SCREENING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 54
6.2 CONSUMABLES 54
TABLE 4 NEWBORN SCREENING CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 54
6.2.1 ASSAY KITS & REAGENTS 55
6.2.1.1 Assay kits & reagents hold the largest share of the
consumables market 55
TABLE 5 ASSAY KITS & REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 55
6.2.2 OTHER CONSUMABLES 55
TABLE 6 OTHER NEWBORN SCREENING CONSUMABLES MARKET, BY REGION,
2019–2026 (USD MILLION) 56
6.3 INSTRUMENTS 56
TABLE 7 NEWBORN SCREENING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 56
6.3.1 NEWBORN DISORDER SCREENING INSTRUMENTS 57
TABLE 8 NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 57
TABLE 9 NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 57
6.3.1.1 Fully automated instruments 57
6.3.1.1.1 Fully automated instruments dominate the disorder screening instruments market 57
TABLE 10 FULLY AUTOMATED INSTRUMENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 58
6.3.1.2 Other instruments 58
TABLE 11 OTHER NEWBORN DISORDER SCREENING INSTRUMENTS MARKET,
BY REGION, 2019–2026 (USD MILLION) 58
6.3.2 NEWBORN HEARING SCREENING INSTRUMENTS 59
TABLE 12 NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 59
TABLE 13 NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 59
6.3.2.1 Accessories 59
6.3.2.1.1 The accessories segment dominates the hearing screening instruments market 59
TABLE 14 ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION) 60
6.3.2.2 Devices 60
6.3.2.2.1 Government recommendations ensure sustained demand for hearing screening devices 60
TABLE 15 DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 60
6.3.3 PULSE OXIMETERS 61
6.3.3.1 The high prevalence of CCHD and recommendations for pulse oximetry testing drive the market growth 61
TABLE 16 PULSE OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION) 61
7 NEWBORN SCREENING MARKET, BY TEST 62
7.1 INTRODUCTION 63
TABLE 17 NEWBORN SCREENING MARKET, BY TEST, 2018–2026 (USD MILLION) 63
7.2 DRY BLOOD SPOT TESTS 63
7.2.1 DRY BLOOD SPOT TESTS DOMINATE THE NEWBORN SCREENING MARKET 63
TABLE 18 NEWBORN DRY BLOOD SPOT TESTS MARKET, BY REGION,
2019–2026 (USD MILLION) 63
7.3 HEARING SCREENING TESTS 64
7.3.1 RECOMMENDATIONS FROM GOVERNMENT ORGANIZATIONS TO
SUPPORT THE MARKET GROWTH 64
TABLE 19 NEWBORN HEARING SCREENING TESTS MARKET, BY REGION,
2018–2026 (USD MILLION) 64
7.4 CRITICAL CONGENITAL HEART DEFECT SCREENING TESTS 65
7.4.1 APAC TO SHOW RISING DEMAND FOR CCHD SCREENING TESTS 65
TABLE 20 NEWBORN CCHD SCREENING TESTS MARKET, BY REGION,
2019–2026 (USD MILLION) 65
8 NEWBORN SCREENING MARKET, BY TECHNOLOGY 66
8.1 INTRODUCTION 67
TABLE 21 NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 67
8.2 IMMUNOASSAYS & ENZYMATIC ASSAYS 67
8.2.1 ENZYMATIC AND IMMUNOASSAYS DOMINATE THE NEWBORN SCREENING MARKET, BY TECHNOLOGY 67
TABLE 22 NEWBORN SCREENING MARKET FOR IMMUNOASSAYS & ENZYMATIC ASSAYS, BY REGION, 2019–2026 (USD MILLION) 68
8.3 TANDEM MASS SPECTROMETRY 68
8.3.1 NORTH AMERICA HOLDS THE LARGEST SHARE OF THE TANDEM MASS SPECTROMETRY MARKET 68
TABLE 23 NEWBORN SCREENING MARKET FOR TANDEM MASS SPECTROMETRY,
BY REGION, 2018–2026 (USD MILLION) 69
8.4 MOLECULAR ASSAYS 69
8.4.1 RISING NUMBER OF SEVERE COMBINED IMMUNODEFICIENCY CASES IN NEWBORNS TO SUPPORT THE MARKET GROWTH 69
TABLE 24 NEWBORN SCREENING MARKET FOR MOLECULAR ASSAYS, BY REGION, 2018–2026 (USD MILLION) 69

8.5 HEARING SCREENING TECHNOLOGIES 70
8.5.1 APAC EXPECTED TO REGISTER HIGHEST GROWTH RATE IN THIS MARKET 70
TABLE 25 NEWBORN SCREENING MARKET FOR HEARING SCREENING TECHNOLOGIES, BY REGION, 2018–2026 (USD MILLION) 70
8.6 PULSE OXIMETRY 70
8.6.1 INCREASING PREVALENCE OF CCHD TO SUPPORT THE MARKET GROWTH 70
TABLE 26 NEWBORN SCREENING MARKET FOR PULSE OXIMETRY, BY REGION,
2018–2026 (USD MILLION) 71
8.7 OTHER TECHNOLOGIES 71
TABLE 27 OTHER NEWBORN SCREENING TECHNOLOGIES MARKET, BY REGION,
2018–2026 (USD MILLION) 71
9 NEWBORN SCREENING MARKET, BY END USER 72
9.1 INTRODUCTION 73
TABLE 28 NEWBORN SCREENING MARKET, BY END USER, 2019–2026 (USD MILLION) 73
9.2 CLINICAL LABORATORIES 73
9.2.1 PRESENCE OF SKILLED PROFESSIONAL AND ROBUST INFRASTRUCTURE TO SUPPORT THE MARKET GROWTH 73
TABLE 29 NEWBORN SCREENING MARKET FOR CLINICAL LABORATORIES, BY REGION, 2018–2026 (USD MILLION) 73
9.3 HOSPITALS 74
9.3.1 NORTH AMERICA DOMINATES THE HOSPITALS SEGMENT 74
TABLE 30 NEWBORN SCREENING MARKET FOR HOSPITALS, BY REGION,
2018–2026 (USD MILLION) 74
10 NEWBORN SCREENING MARKET, BY REGION 75
10.1 INTRODUCTION 76
TABLE 31 NEWBORN SCREENING MARKET, BY REGION, 2019–2026 (USD MILLION) 76
10.2 NORTH AMERICA 76
FIGURE 22 NORTH AMERICA: NEWBORN SCREENING MARKET SNAPSHOT 77
TABLE 32 NORTH AMERICA: NEWBORN SCREENING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 77
TABLE 33 NORTH AMERICA: NEWBORN SCREENING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 78
TABLE 34 NORTH AMERICA: NEWBORN SCREENING MARKET FOR CONSUMABLES,
BY TYPE, 2019–2026 (USD MILLION) 78
TABLE 35 NORTH AMERICA: NEWBORN SCREENING MARKET FOR INSTRUMENTS,
BY TYPE, 2019–2026 (USD MILLION) 78
TABLE 36 NORTH AMERICA: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 79
TABLE 37 NORTH AMERICA: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 79
TABLE 38 NORTH AMERICA: NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 79
TABLE 39 NORTH AMERICA: NEWBORN SCREENING MARKET, BY TEST,
2019–2026 (USD MILLION) 80
TABLE 40 NORTH AMERICA: NEWBORN SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION) 80
10.2.1 US 80
10.2.1.1 Availability of reimbursement in the country is expected to support the market growth 80
TABLE 41 US: NEWBORN SCREENING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 81
TABLE 42 US: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE,
2019–2026 (USD MILLION) 81
TABLE 43 US: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE,
2019–2026 (USD MILLION) 81
TABLE 44 US: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 82
TABLE 45 US: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 82
TABLE 46 US: NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 82
TABLE 47 US: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION) 83
TABLE 48 US: NEWBORN SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION) 83
10.2.2 CANADA 83
10.2.2.1 Investments for newborn screening in Canada to
support market growth 83
TABLE 49 CANADA: NEWBORN SCREENING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 84
TABLE 50 CANADA: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION) 84
TABLE 51 CANADA: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION) 84
TABLE 52 CANADA: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 85
TABLE 53 CANADA: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 85
TABLE 54 CANADA: NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 85
TABLE 55 CANADA: NEWBORN SCREENING MARKET, BY TEST,
2019–2026 (USD MILLION) 86
TABLE 56 CANADA: NEWBORN SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION) 86
10.3 EUROPE 87
TABLE 57 EUROPE: NEWBORN SCREENING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 87
TABLE 58 EUROPE: NEWBORN SCREENING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 87
TABLE 59 EUROPE: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION) 88
TABLE 60 EUROPE: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION) 88
TABLE 61 EUROPE: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 88
TABLE 62 EUROPE: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 89
TABLE 63 EUROPE: NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 89
TABLE 64 EUROPE: NEWBORN SCREENING MARKET, BY TEST,
2019–2026 (USD MILLION) 89
TABLE 65 EUROPE: NEWBORN SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION) 90
10.3.1 GERMANY 90
10.3.1.1 Germany holds the largest share of the European
newborn screening market 90
TABLE 66 GERMANY: NEWBORN SCREENING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 90
TABLE 67 GERMANY: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION) 91
TABLE 68 GERMANY: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION) 91
TABLE 69 GERMANY: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 91
TABLE 70 GERMANY: NEWBORN HEARING SCREENING INSTRUMENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 92
TABLE 71 GERMANY: NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 92
TABLE 72 GERMANY: NEWBORN SCREENING MARKET, BY TEST,
2019–2026 (USD MILLION) 92
TABLE 73 GERMANY: NEWBORN SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION) 93
10.3.2 FRANCE 93
10.3.2.1 France accounted for the second-largest market share in Europe 93
TABLE 74 FRANCE: NEWBORN SCREENING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 93
TABLE 75 FRANCE: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION) 94
TABLE 76 FRANCE: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION) 94
TABLE 77 FRANCE: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 94
TABLE 78 FRANCE: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 95
TABLE 79 FRANCE: NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 95
TABLE 80 FRANCE: NEWBORN SCREENING MARKET, BY TEST,
2019–2026 (USD MILLION) 95
TABLE 81 FRANCE: NEWBORN SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION) 96

10.3.3 UK 96
10.3.3.1 Favorable initiatives and reimbursement scenario indicate strong prospects for market growth 96
TABLE 82 UK: NEWBORN SCREENING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 96
TABLE 83 UK: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE,
2019–2026 (USD MILLION) 96
TABLE 84 UK: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE,
2019–2026 (USD MILLION) 97
TABLE 85 UK: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 97
TABLE 86 UK: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 97
TABLE 87 UK: NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 98
TABLE 88 UK: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION) 98
TABLE 89 UK: NEWBORN SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION) 98
10.3.4 SPAIN 99
10.3.4.1 Availability of health insurance to support the market
growth in the country 99
TABLE 90 SPAIN: NEWBORN SCREENING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 99
TABLE 91 SPAIN: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION) 99
TABLE 92 SPAIN: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE,
2019–2026 (USD MILLION) 99
TABLE 93 SPAIN: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 100
TABLE 94 SPAIN: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 100
TABLE 95 SPAIN: NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 100
TABLE 96 SPAIN: NEWBORN SCREENING MARKET, BY TEST,
2019–2026 (USD MILLION) 101
TABLE 97 SPAIN: NEWBORN SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION) 101
10.3.5 ITALY 101
10.3.5.1 Amendments by the Italian government support newborn
screening in the country 101
TABLE 98 ITALY: NEWBORN SCREENING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 102
TABLE 99 ITALY: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE,
2019–2026 (USD MILLION) 102
TABLE 100 ITALY: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE,
2019–2026 (USD MILLION) 102
TABLE 101 ITALY: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 103
TABLE 102 ITALY: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 103
TABLE 103 ITALY: NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 103
TABLE 104 ITALY: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION) 104
TABLE 105 ITALY: NEWBORN SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION) 104
10.3.6 REST OF EUROPE 104
TABLE 106 ROE: HEALTH EXPENDITURE (% OF GDP), 2010–2017 104
TABLE 107 ROE: NEWBORN SCREENING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 105
TABLE 108 ROE: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE,
2019–2026 (USD MILLION) 105
TABLE 109 ROE: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE,
2019–2026 (USD MILLION) 105
TABLE 110 ROE: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 106
TABLE 111 ROE: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 106
TABLE 112 ROE: NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 106
TABLE 113 ROE: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION) 107
TABLE 114 ROE: NEWBORN SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION) 107
10.4 ASIA PACIFIC 108
TABLE 115 ASIA PACIFIC: NEWBORN SCREENING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 108
TABLE 116 ASIA PACIFIC: NEWBORN SCREENING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 108
TABLE 117 ASIA PACIFIC: NEWBORN SCREENING MARKET FOR CONSUMABLES,
BY TYPE, 2019–2026 (USD MILLION) 108
TABLE 118 ASIA PACIFIC: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION) 109
TABLE 119 ASIA PACIFIC: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 109
TABLE 120 ASIA PACIFIC: NEWBORN HEARING SCREENING INSTRUMENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 109
TABLE 121 ASIA PACIFIC: NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 110
TABLE 122 ASIA PACIFIC: NEWBORN SCREENING MARKET, BY TEST,
2019–2026 (USD MILLION) 110
TABLE 123 ASIA PACIFIC: NEWBORN SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION) 110
10.4.1 CHINA 111
10.4.1.1 China dominates the newborn screening market in the APAC 111
TABLE 124 CHINA: NEWBORN SCREENING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 111
TABLE 125 CHINA: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION) 111
TABLE 126 CHINA: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE,
2019–2026 (USD MILLION) 112
TABLE 127 CHINA: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 112
TABLE 128 CHINA: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 112
TABLE 129 CHINA: NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 113
TABLE 130 CHINA: NEWBORN SCREENING MARKET, BY TEST,
2019–2026 (USD MILLION) 113
TABLE 131 CHINA: NEWBORN SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION) 113
10.4.2 JAPAN 114
10.4.2.1 Rising testing volumes and growing healthcare expenditure
drive the market 114
TABLE 132 JAPAN: NEWBORN SCREENING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 114
TABLE 133 JAPAN: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION) 114
TABLE 134 JAPAN: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE,
2019–2026 (USD MILLION) 115
TABLE 135 JAPAN: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 115
TABLE 136 JAPAN: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 115
TABLE 137 JAPAN: NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 116
TABLE 138 JAPAN: NEWBORN SCREENING MARKET, BY TEST,
2019–2026 (USD MILLION) 116
TABLE 139 JAPAN: NEWBORN SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION) 116
10.4.3 AUSTRALIA 117
10.4.3.1 Favorable government policies in the country drive the
growth of the market 117
TABLE 140 AUSTRALIA: NEWBORN SCREENING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 117
TABLE 141 AUSTRALIA: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION) 117
TABLE 142 AUSTRALIA: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION) 118
TABLE 143 AUSTRALIA: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 118
TABLE 144 AUSTRALIA: NEWBORN HEARING SCREENING INSTRUMENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 118
TABLE 145 AUSTRALIA: NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 119
TABLE 146 AUSTRALIA: NEWBORN SCREENING MARKET, BY TEST,
2019–2026 (USD MILLION) 119
TABLE 147 AUSTRALIA: NEWBORN SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION) 119
10.4.4 REST OF ASIA PACIFIC 120
TABLE 148 ROAPAC: NEWBORN SCREENING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 120
TABLE 149 ROAPAC: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE, 2019–2026 (USD MILLION) 120
TABLE 150 ROAPAC: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 151 ROAPAC: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 152 ROAPAC: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 153 ROAPAC: NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 122
TABLE 154 ROAPAC: NEWBORN SCREENING MARKET, BY TEST,
2019–2026 (USD MILLION) 122
TABLE 155 ROAPAC: NEWBORN SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION) 122
10.5 REST OF THE WORLD 123
TABLE 156 ROW: NEWBORN SCREENING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 123
TABLE 157 ROW: NEWBORN SCREENING MARKET FOR CONSUMABLES, BY TYPE,
2019–2026 (USD MILLION) 123
TABLE 158 ROW: NEWBORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE,
2019–2026 (USD MILLION) 124
TABLE 159 ROW: NEWBORN DISORDER SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 124
TABLE 160 ROW: NEWBORN HEARING SCREENING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 124
TABLE 161 ROW: NEWBORN SCREENING MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 125
TABLE 162 ROW: NEWBORN SCREENING MARKET, BY TEST, 2019–2026 (USD MILLION) 125
TABLE 163 ROW: NEWBORN SCREENING MARKET, BY END USER,
2019–2026 (USD MILLION) 125
11 COMPETITIVE LANDSCAPE 126
11.1 OVERVIEW 126
FIGURE 23 KEY DEVELOPMENTS IN THE NEWBORN SCREENING MARKET,
JANUARY 2017–NOVEMBER 2020 126
FIGURE 24 MARKET EVOLUTION FRAMEWORK: JANUARY 2017 TO JANUARY 2021 127
11.2 MARKET SHARE ANALYSIS 128
FIGURE 25 NEWBORN SCREENING MARKET SHARE ANALYSIS, 2019 128
11.3 COMPANY EVALUATION MATRIX 129
11.3.1 STARS 129
11.3.2 EMERGING LEADERS 129
11.3.3 PERVASIVE PLAYERS 129
11.3.4 PARTICIPANTS 129
FIGURE 26 VENDOR DIVE: NEWBORN SCREENING MARKET 130
11.4 COMPETITIVE LEADERSHIP MAPPING (START-UPS) 131
11.4.1 PROGRESSIVE COMPANIES 131
11.4.2 STARTING BLOCKS 131
11.4.3 RESPONSIVE COMPANIES 131
11.4.4 DYNAMIC COMPANIES 131
FIGURE 27 VENDOR DIVE MATRIX FOR START-UPS: NEWBORN SCREENING MARKET 132
11.5 COMPETITIVE SCENARIO 133
11.5.1 PRODUCT LAUNCHES & APPROVALS 133
TABLE 164 NEWBORN SCREENING MARKET: PRODUCT LAUNCHES &
APPROVALS, 2017–2021 133
11.5.2 DEALS 134
TABLE 165 NEWBORN SCREENING MARKET: DEALS 2017–2021 134
11.5.3 OTHER DEVELOPMENTS 134
TABLE 166 NEWBORN SCREENING MARKET: OTHER DEVELOPMENTS, 2017–2021 134
FIGURE 28 PRODUCT BENCHMARKING 135
FIGURE 29 GEOGRAPHIC ASSESSMENT 135
12 COMPANY PROFILES 136
12.1 MAJOR PLAYERS 136
(Business Overview, Products Offered, Recent Developments, and MnM View)*
12.1.1 PERKINELMER 136
FIGURE 30 PERKINELMER: COMPANY SNAPSHOT (2019) 136
12.1.2 DEMANT 139
FIGURE 31 DEMANT A/S: COMPANY SNAPSHOT (2019) 139
12.1.3 NATUS MEDICAL 141
FIGURE 32 NATUS MEDICAL: COMPANY SNAPSHOT (2019) 141
12.1.4 MASIMO 143
FIGURE 33 MASIMO: COMPANY SNAPSHOT (2019) 143
12.1.5 AB SCIEX 145
FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 145
12.1.6 MEDTRONIC 147
FIGURE 35 MEDTRONIC: COMPANY SNAPSHOT (2019) 147
12.1.7 BAEBIES 148
12.1.8 INTELLIGENT HEARING SYSTEMS CORP. 149
12.1.9 WELCH ALLYN 150
FIGURE 36 HILL-ROM HOLDINGS: COMPANY SNAPSHOT (2019) 150
12.1.10 WATERS CORPORATION 151
12.1.11 THERMO FISHER SCIENTIFIC 152
12.1.12 TRIVITRON HEALTHCARE 153
12.2 START-UPS/SME PLAYERS 155
12.2.1 BIO-RAD LABORATORIES 155
FIGURE 37 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019) 155
12.2.2 CHROMSYSTEMS INSTRUMENTS & CHEMICALS 156
12.2.3 PARSEQ LAB 157
12.2.4 RECIPE CHEMICALS + INSTRUMENTS GMBH 158
12.2.5 ZIVAK TECHNOLOGIES 159
12.2.6 CAMAG 160
12.2.7 OTODYNAMICS 161
12.2.8 ZENTECH 162
12.2.9 VIVOSONIC 163
12.2.10 MP BIOMEDICALS 164
12.2.11 CENTOGENE 165
12.2.12 DRG INTERNATIONAL 166
12.2.13 REGIS TECHNOLOGIES 167
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
13 APPENDIX 168
13.1 INSIGHTS FROM INDUSTRY EXPERTS 168
13.2 DISCUSSION GUIDE 169
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 174
13.4 AVAILABLE CUSTOMIZATIONS 176
13.5 RELATED REPORTS 176
13.6 AUTHOR DETAILS 177



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の新生児スクリーニング市場(~2026年):製品別(機器、消耗品)、検査種類別(乾燥血液スポット、聴覚スクリーニング、CCHD)、技術別(タンデム質量分析、イムノアッセイ、酵素アッセイ、分子、パルスオキシメトリ)、エンドユーザー別(病院)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆